KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$161000.0.

  • Castle Biosciences' Other Working Capital Changes fell 10762.67% to -$161000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 897.08%. This contributed to the annual value of -$1.3 million for FY2024, which is 25129.11% down from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Other Working Capital Changes is -$161000.0, which was down 10762.67% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Other Working Capital Changes registered a high of $3.4 million during Q1 2025, and its lowest value of -$3.2 million during Q3 2021.
  • For the 5-year period, Castle Biosciences' Other Working Capital Changes averaged around -$159368.4, with its median value being -$161000.0 (2025).
  • As far as peak fluctuations go, Castle Biosciences' Other Working Capital Changes plummeted by 140155.04% in 2021, and later soared by 146370.37% in 2024.
  • Castle Biosciences' Other Working Capital Changes (Quarter) stood at -$3.0 million in 2021, then soared by 78.46% to -$646000.0 in 2022, then skyrocketed by 62.69% to -$241000.0 in 2023, then plummeted by 1131.54% to -$3.0 million in 2024, then soared by 94.58% to -$161000.0 in 2025.
  • Its Other Working Capital Changes stands at -$161000.0 for Q3 2025, versus $1.3 million for Q2 2025 and $3.4 million for Q1 2025.